
# PhenoGnet: A Graph-Based Contrastive Learning Framework for Disease Similarity Prediction

**Korean Title:** PhenoGnet: ì§ˆë³‘ ìœ ì‚¬ì„± ì˜ˆì¸¡ì„ ìœ„í•œ ê·¸ë˜í”„ ê¸°ë°˜ ëŒ€ì¡° í•™ìŠµ í”„ë ˆì„ì›Œí¬

## ğŸ“‹ ë©”íƒ€ë°ì´í„°

**Links**: [[daily/2025-09-17|2025-09-17]] [[authors/Ranga Baminiwatte|Ranga Baminiwatte]] [[authors/Kazi Jewel Rana|Kazi Jewel Rana]] [[authors/Aaron J. Masino|Aaron J. Masino]] [[categories/cs.AI|cs.AI]]

## ğŸ·ï¸ ì¹´í…Œê³ ë¦¬í™”ëœ í‚¤ì›Œë“œ
**ğŸ”¬ Broad Technical**: Graph Convolutional Networks, Graph Attention Networks

## ğŸ”— ìœ ì‚¬í•œ ë…¼ë¬¸
- [[A Geometric Graph-Based Deep Learning Model for Drug-Target Affinity Prediction]] (78.7% similar)
- [[Causal Clustering for Conditional Average Treatment Effects Estimation and Subgroup Discovery]] (77.1% similar)
- [[Locally_Explaining_Prediction_Behavior_via_Gradual_Interventions_and_Measuring_Property_Gradients_20250918|Locally Explaining Prediction Behavior via Gradual Interventions and Measuring Property Gradients]] (77.1% similar)
- [[Taylor-Series_Expanded_Kolmogorov-Arnold_Network_for_Medical_Imaging_Classification_20250918|Taylor-Series Expanded Kolmogorov-Arnold Network for Medical Imaging Classification]] (76.3% similar)
- [[Intelligent Healthcare Imaging Platform An VLM-Based Framework for Automated Medical Image Analysis and Clinical Report Generation]] (76.0% similar)

## ğŸ“‹ ì €ì ì •ë³´

**Authors:** Ranga Baminiwatte, Kazi Jewel Rana, Aaron J. Masino

## ğŸ“„ Abstract (ì›ë¬¸)

Understanding disease similarity is critical for advancing diagnostics, drug
discovery, and personalized treatment strategies. We present PhenoGnet, a novel
graph-based contrastive learning framework designed to predict disease
similarity by integrating gene functional interaction networks with the Human
Phenotype Ontology (HPO). PhenoGnet comprises two key components: an intra-view
model that separately encodes gene and phenotype graphs using Graph
Convolutional Networks (GCNs) and Graph Attention Networks (GATs), and a cross
view model implemented as a shared weight multilayer perceptron (MLP) that
aligns gene and phenotype embeddings through contrastive learning. The model is
trained using known gene phenotype associations as positive pairs and randomly
sampled unrelated pairs as negatives. Diseases are represented by the mean
embeddings of their associated genes and/or phenotypes, and pairwise similarity
is computed via cosine similarity. Evaluation on a curated benchmark of 1,100
similar and 866 dissimilar disease pairs demonstrates strong performance, with
gene based embeddings achieving an AUCPR of 0.9012 and AUROC of 0.8764,
outperforming existing state of the art methods. Notably, PhenoGnet captures
latent biological relationships beyond direct overlap, offering a scalable and
interpretable solution for disease similarity prediction. These results
underscore its potential for enabling downstream applications in rare disease
research and precision medicine.

## ğŸ” Abstract (í•œê¸€ ë²ˆì—­)

ì§ˆë³‘ ìœ ì‚¬ì„±ì„ ì´í•´í•˜ëŠ” ê²ƒì€ ì§„ë‹¨, ì•½ë¬¼ ë°œê²¬ ë° ë§ì¶¤ ì¹˜ë£Œ ì „ëµì„ ë°œì „ì‹œí‚¤ëŠ” ë° ì¤‘ìš”í•©ë‹ˆë‹¤. ìš°ë¦¬ëŠ” ìœ ì „ì ê¸°ëŠ¥ ìƒí˜¸ ì‘ìš© ë„¤íŠ¸ì›Œí¬ë¥¼ ì¸ê°„ í‘œí˜„í˜• ì˜¨í†¨ë¡œì§€ (HPO)ì™€ í†µí•©í•˜ì—¬ ì§ˆë³‘ ìœ ì‚¬ì„±ì„ ì˜ˆì¸¡í•˜ê¸° ìœ„í•´ ì„¤ê³„ëœ í˜ì‹ ì ì¸ ê·¸ë˜í”„ ê¸°ë°˜ ëŒ€ì¡°ì  í•™ìŠµ í”„ë ˆì„ì›Œí¬ ì¸ PhenoGnetì„ ì œì‹œí•©ë‹ˆë‹¤. PhenoGnetì€ ë‘ ê°€ì§€ ì£¼ìš” êµ¬ì„± ìš”ì†Œë¡œ êµ¬ì„±ë˜ì–´ ìˆìŠµë‹ˆë‹¤. ê·¸ë˜í”„ í•©ì„±ê³± ì‹ ê²½ë§ (GCN) ë° ê·¸ë˜í”„ ì£¼ì˜ ì‹ ê²½ë§ (GAT)ì„ ì‚¬ìš©í•˜ì—¬ ìœ ì „ì ë° í‘œí˜„í˜• ê·¸ë˜í”„ë¥¼ ê°ê° ì¸ì½”ë”©í•˜ëŠ” intra-view ëª¨ë¸ê³¼, ëŒ€ì¡°ì  í•™ìŠµì„ í†µí•´ ìœ ì „ì ë° í‘œí˜„í˜• ì„ë² ë”©ì„ ì •ë ¬í•˜ëŠ” ê³µìœ  ê°€ì¤‘ì¹˜ ë‹¤ì¸µ í¼ì…‰íŠ¸ë¡  (MLP)ìœ¼ë¡œ êµ¬í˜„ëœ cross view ëª¨ë¸ë¡œ êµ¬ì„±ë©ë‹ˆë‹¤. ì´ ëª¨ë¸ì€ ì•Œë ¤ì§„ ìœ ì „ì í‘œí˜„í˜• ì—°ê´€ì„ ì–‘ì„± ìŒìœ¼ë¡œ ì‚¬ìš©í•˜ê³  ê´€ë ¨ ì—†ëŠ” ìŒì„ ë¬´ì‘ìœ„ë¡œ ìƒ˜í”Œë§í•˜ì—¬ í›ˆë ¨ë©ë‹ˆë‹¤. ì§ˆë³‘ì€ ê´€ë ¨ëœ ìœ ì „ì ë°/ë˜ëŠ” í‘œí˜„í˜•ì˜ í‰ê·  ì„ë² ë”©ìœ¼ë¡œ í‘œí˜„ë˜ë©°, ì½”ì‚¬ì¸ ìœ ì‚¬ì„±ì„ í†µí•´ ìŒë³„ ìœ ì‚¬ì„±ì´ ê³„ì‚°ë©ë‹ˆë‹¤. 1,100ê°œì˜ ìœ ì‚¬í•˜ê³  866ê°œì˜ ìœ ì‚¬í•˜ì§€ ì•Šì€ ì§ˆë³‘ ìŒìœ¼ë¡œ êµ¬ì„±ëœ ì •ì œëœ ë²¤ì¹˜ë§ˆí¬ì—ì„œì˜ í‰ê°€ëŠ” ìœ ì „ì ê¸°ë°˜ ì„ë² ë”©ì´ AUCPR 0.9012 ë° AUROC 0.8764ë¥¼ ë‹¬ì„±í•˜ì—¬ ê¸°ì¡´ì˜ ìµœì²¨ë‹¨ ë°©ë²•ì„ ëŠ¥ê°€í•˜ëŠ” ê°•ë ¥í•œ ì„±ëŠ¥ì„ ë³´ì—¬ì¤ë‹ˆë‹¤. íŠ¹íˆ PhenoGnetì€ ì§ì ‘ì ì¸ ì¤‘ì²©ì„ ë„˜ì–´ ìˆ¨ê²¨ì§„ ìƒë¬¼í•™ì  ê´€ê³„ë¥¼ í¬ì°©í•˜ì—¬ ì§ˆë³‘ ìœ ì‚¬ì„± ì˜ˆì¸¡ì„ ìœ„í•œ í™•ì¥ ê°€ëŠ¥í•˜ê³  í•´ì„ ê°€ëŠ¥í•œ ì†”ë£¨ì…˜ì„ ì œê³µí•©ë‹ˆë‹¤. ì´ëŸ¬í•œ ê²°ê³¼ëŠ” í¬ê·€ ì§ˆë³‘ ì—°êµ¬ ë° ì •ë°€ ì˜í•™ì—ì„œ í•˜ë¥˜ ì‘ìš© í”„ë¡œê·¸ë¨ì„ ê°€ëŠ¥í•˜ê²Œ í•˜ëŠ” ì ì¬ë ¥ì„ ê°•ì¡°í•©ë‹ˆë‹¤.

## ğŸ“ ìš”ì•½

ë³‘ë¦¬ ìœ ì‚¬ì„±ì„ ì´í•´í•˜ëŠ” ê²ƒì€ ì§„ë‹¨, ì•½ë¬¼ ë°œê²¬ ë° ë§ì¶¤ ì¹˜ë£Œ ì „ëµì„ ë°œì „ì‹œí‚¤ëŠ” ë° ì¤‘ìš”í•©ë‹ˆë‹¤. ë³¸ ì—°êµ¬ëŠ” ìœ ì „ì ê¸°ëŠ¥ ìƒí˜¸ì‘ìš© ë„¤íŠ¸ì›Œí¬ì™€ ì¸ê°„ í‘œí˜„í˜• ì˜¨í†¨ë¡œì§€(HPO)ë¥¼ í†µí•©í•˜ì—¬ ì§ˆë³‘ ìœ ì‚¬ì„±ì„ ì˜ˆì¸¡í•˜ëŠ” ìƒˆë¡œìš´ ê·¸ë˜í”„ ê¸°ë°˜ ëŒ€ì¡° í•™ìŠµ í”„ë ˆì„ì›Œí¬ ì¸ PhenoGnetì„ ì œì•ˆí•©ë‹ˆë‹¤. PhenoGnetì€ GCN ë° GATë¥¼ ì‚¬ìš©í•˜ì—¬ ìœ ì „ì ë° í‘œí˜„í˜• ê·¸ë˜í”„ë¥¼ ë”°ë¡œ ì¸ì½”ë”©í•˜ëŠ” intra-view ëª¨ë¸ê³¼ ìœ ì „ì ë° í‘œí˜„í˜• ì„ë² ë”©ì„ ëŒ€ì¡° í•™ìŠµì„ í†µí•´ ì •ë ¬í•˜ëŠ” cross-view ëª¨ë¸ë¡œ êµ¬ì„±ë©ë‹ˆë‹¤. ì´ ëª¨ë¸ì€ ì•Œë ¤ì§„ ìœ ì „ì í‘œí˜„í˜• ì—°ê´€ì„ ì–‘ì„± ìŒìœ¼ë¡œ, ê´€ë ¨ ì—†ëŠ” ìŒì„ ìŒì„±ìœ¼ë¡œ ì‚¬ìš©í•˜ì—¬ í›ˆë ¨ë©ë‹ˆë‹¤. PhenoGnetì€ ì§ˆë³‘ì„ ê´€ë ¨ëœ ìœ ì „ì ë°/ë˜ëŠ” í‘œí˜„í˜•ì˜ í‰ê·  ì„ë² ë”©ìœ¼ë¡œ í‘œí˜„í•˜ê³ , ì½”ì‚¬ì¸ ìœ ì‚¬ë„ë¥¼ í†µí•´ ìŒë³„ ìœ ì‚¬ì„±ì„ ê³„ì‚°í•©ë‹ˆë‹¤. 1,100ê°œì˜ ìœ ì‚¬ ë° 866ê°œì˜ ë¹„ìœ ì‚¬ ì§ˆë³‘ ìŒìœ¼ë¡œ êµ¬ì„±ëœ ë²¤ì¹˜ë§ˆí¬ì—ì„œ ê°•ë ¥í•œ ì„±ëŠ¥ì„ ë³´ì—¬ì£¼ë©°, ê¸°ì¡´ ìµœì²¨ë‹¨ ë°©ë²•ì„ ëŠ¥ê°€í•˜ëŠ” AUCPR 0.9012 ë° AUROC 0.8764ë¥¼ ë‹¬ì„±í–ˆìŠµë‹ˆë‹¤. íŠ¹íˆ, PhenoGnetì€ ì§ì ‘ì ì¸ ì¤‘ì²©ì„ ë„˜ì–´ ìˆ¨ê²¨ì§„ ìƒë¬¼í•™ì  ê´€ê³„ë¥¼ í¬ì°©í•˜ì—¬, ì§ˆë³‘ ìœ ì‚¬ì„± ì˜ˆì¸¡ì— ëŒ€í•œ í™•ì¥ ê°€ëŠ¥í•˜ê³  í•´ì„ ê°€ëŠ¥í•œ ì†”ë£¨ì…˜ì„ ì œê³µí•©ë‹ˆë‹¤. ì´ëŸ¬í•œ ê²°ê³¼ëŠ” í¬ê·€ ì§ˆë³‘ ì—°êµ¬ ë° ì •ë°€ ì˜í•™ì—ì„œ í•˜ë¥˜ ì‘ìš© í”„ë¡œê·¸ë¨ì„ ê°€ëŠ¥í•˜ê²Œ í•˜ëŠ” ì ì¬ë ¥ì„ ê°•ì¡°í•©ë‹ˆë‹¤.

## ğŸ¯ ì£¼ìš” í¬ì¸íŠ¸

- ì§ˆë³‘ ìœ ì‚¬ì„±ì„ ì˜ˆì¸¡í•˜ê¸° ìœ„í•œ ìƒˆë¡œìš´ ê·¸ë˜í”„ ê¸°ë°˜ ëŒ€ì¡° í•™ìŠµ í”„ë ˆì„ì›Œí¬ì¸ PhenoGnetì„ ì œì•ˆí•œë‹¤.

- PhenoGnetì€ ìœ ì „ì ê¸°ëŠ¥ ìƒí˜¸ì‘ìš© ë„¤íŠ¸ì›Œí¬ì™€ ì¸ê°„ í‘œí˜„í˜• ì˜¨í†¨ë¡œì§€(HPO)ë¥¼ í†µí•©í•˜ì—¬ ì§ˆë³‘ ìœ ì‚¬ì„±ì„ ì˜ˆì¸¡í•œë‹¤.

- ëª¨ë¸ì€ ì•Œë ¤ì§„ ìœ ì „ì í‘œí˜„í˜• ì—°ê´€ì„ ì‚¬ìš©í•˜ì—¬ í•™ìŠµë˜ë©°, ì½”ì‚¬ì¸ ìœ ì‚¬ë„ë¥¼ í†µí•´ ì§ˆë³‘ ê°„ ìœ ì‚¬ì„±ì„ ê³„ì‚°í•œë‹¤.

- PhenoGnetì€ ì§ì ‘ì ì¸ ì¤‘ì²©ì„ ë„˜ì–´ ìƒë¬¼í•™ì  ê´€ê³„ë¥¼ í¬ì°©í•˜ë©°, í¬ê·€ ì§ˆë³‘ ì—°êµ¬ì™€ ì •ë°€ ì˜í•™ ë¶„ì•¼ì—ì„œ í™œìš© ê°€ëŠ¥ì„±ì„ ë³´ì—¬ì¤€ë‹¤.

---

*Generated on 2025-09-18 17:04:59*